| BIONTECH SE SPON. ADRS 1 |
| USA |
| Gesundheit |
| US09075V1026 / A2PSR2 |
| 22UA (Frankfurt) / BNTX (NASDAQ) |
| FRA:22UA, ETR:22UA, 22UA:GR, NASDAQ:BNTX |
| - |
| https://biontech.de/ |
|
BioNTech SE American Depositary Share is the U.S.-traded depositary share of BioNTech SE, a Germany-based biotechnology company focused on immunotherapy and vaccines. The company develops cancer therapeutics, including individualized treatment approa..
>Volltext.. |
| 20972.45 Mio. EUR |
| 6568.98 Mio. EUR |
| 2693.88 Mio. EUR |
| -325.21 Mio. EUR |
| -1712.07 Mio. EUR |
| -6.84 EUR |
| 314.85 Mio. EUR |
| 9702.51 Mio. EUR |
| 632.16 Mio. EUR |
| 7.58 |
| -1.05% |
| -415.28% |
| - |
| - |
| - |
| 02.06.22 - 1.8290012€ |
| 1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 31.740.178 Euro. |
| BIONTECH |
| 19.09.26 |
|
||||
|
||||
|